• SPX
  • $5,916.43
  • -0.01 %
  • -$0.68
  • DJI
  • $43,464.54
  • 0.13 %
  • $56.06
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,127.91
  • 0.53 %
  • $42.84
  • IXIC
  • $18,938.69
  • -0.14 %
  • -$27.45
CalAmp Corp. (CAMP) Stock Price, News & Analysis

CalAmp Corp. (CAMP) Stock Price, News & Analysis

Currency in USD Disclaimer

$6.00

$0.67

(12.57%)

Day's range
$6
Day's range
$6
50-day range
$0.11
Day's range
$12.3
  • Country: US
  • ISIN: US1281262089
52 wk range
$5.15
Day's range
$12.3


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 0.00
  • Piotroski Score 5.00
  • Grade Sell
  • Symbol (CAMP)
  • Company CAMP4 Therapeutics Corporation
  • Price $6.00
  • Changes Percentage (12.57%)
  • Change $0.67
  • Day Low $6.00
  • Day High $6.00
  • Year High $12.30

CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, auto dealers, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 10/11/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $13.50
  • High Stock Price Target $18.00
  • Low Stock Price Target $5.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$63.02
  • Trailing P/E Ratio -0.01
  • Forward P/E Ratio -0.01
  • P/E Growth -0.01
  • Net Income $-93,261,000

Income Statement

Quarterly

Annual

Latest News of CAMP

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

CAMP4 Therapeutics Corporation Frequently Asked Questions

  • What is the CAMP4 Therapeutics Corporation stock price today?

    Today's price of CAMP4 Therapeutics Corporation is $6.00 — it has increased by +12.57% in the past 24 hours. Watch CAMP4 Therapeutics Corporation stock price performance more closely on the chart.

  • Does CAMP4 Therapeutics Corporation release reports?

    Yes, you can track CAMP4 Therapeutics Corporation's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the CAMP4 Therapeutics Corporation stock forecast?

    Watch the CAMP4 Therapeutics Corporation chart and read a more detailed CAMP4 Therapeutics Corporation stock forecast to see what analysts suggest you do with its shares.

  • What is CAMP4 Therapeutics Corporation stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by CAMP4 Therapeutics Corporation stock ticker.

  • How to buy CAMP4 Therapeutics Corporation stocks?

    Like other stocks, CAMP shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is CAMP4 Therapeutics Corporation's EBITDA?

    CAMP4 Therapeutics Corporation measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in CAMP4 Therapeutics Corporation’s financial statements.

  • What is the CAMP4 Therapeutics Corporation's net income ratio for the financial year 2024?

    The net income ratio for the financial year 2024 is -0.5007839768, which equates to approximately -50.08%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in CAMP4 Therapeutics Corporation stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including CAMP4 Therapeutics Corporation's financials relevant news, and technical analysis. CAMP4 Therapeutics Corporation's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for CAMP4 Therapeutics Corporation stock currently indicates a “sell” signal. For more insights, review CAMP4 Therapeutics Corporation’s technical analysis.

  • A revenue figure for CAMP4 Therapeutics Corporation for its last quarter?

    CAMP4 Therapeutics Corporation published it's last quarterly revenues at $53.63 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.